Gradient Health discloses $2.13 million preferred-equity offering
An October SEC notice reports a fully sold offering to one unnamed investor, separate from the company's earlier $3 million notice.
Gradient Health disclosed $2,132,720 in preferred-equity sales in a Form D filed on October 7, 2026. The Durham medical-data company reported the same amount as its total offering, with one investor and no remaining securities to sell under the notice.
The filing dates the first sale to October 6 and describes preferred shares together with the underlying capital stock into which they may convert. That conversion feature is part of an equity security, rather than a disclosure of convertible debt.
Gradient's earlier 2026 notice reported a separate $3 million offering with an August 13 first sale. The October document is a new notice with its own first-sale date and sold amount; this article reports that offering rather than combining the two into a single August financing. Neither notice names the subscriber or specifies a venture-round stage.
Gradient Health supplies curated, de-identified medical datasets to AI developers and research teams. Its Atlas platform connects healthcare-data partners with customers seeking patient records for model development and validation.